Nick Smith | Senior Director, Corporate Development & IR |
Norbert Riedel | President & CEO |
Ashish Khanna | CFO & Chief Business Officer |
Andy Kidd | COO |
Kathryn King | SVP, Clinical Development |
Rolando Gutierrez | SVP. Medical and Pharmacovigilance |
Joon Lee | Truist Securities |
Charles Duncan | Cantor Fitzgerald |
Marc Goodman | SVB Leerink |
Gary Nachman | BMO Capital Markets |
Ritu Baral | Cowen |
Myles Minter | William Blair |
Good afternoon and welcome to the Aptinyx Second Quarter 2020 Financial Results Conference Call. At this time, all participants are on listen-only mode.
Following the formal remarks, we will open up the call for your questions. Please be advised the call is being recorded at the Company's request. At this time, I'd like to turn the call over to Nick Smith, Senior Director of Corporate Development and Investor Relations at Aptinyx.